ABSTRACT
Proteases play an important role for the proper physiological functions of the most diverse organisms. When unregulated, they are associated with several pathologies. Therefore, proteases have become potential therapeutic targets regarding the search for inhibitors. Snake venoms are complex mixtures of molecules that can feature a variety of functions, including peptidase inhibition. Considering this, the present study reports the purification and characterization of a Kunitz-type peptide present in the Dendroaspis polylepis venom as a simultaneous inhibitor of elastase-1 and cathepsin L. Methods: The low molecular weight pool from D. polylepis venom was fractionated in reverse phase HPLC and all peaks were tested in fluorimetric assays. The selected fraction that presented inhibitory activity over both proteases was submitted to mass spectrometry analysis, and the obtained sequence was determined as a Kunitz-type serine protease inhibitor homolog dendrotoxin I. The molecular docking of the Kunitz peptide on the elastase was carried out in the program Z-DOCK, and the program RosettaDock was used to add hydrogens to the models, which were re-ranked using ZRANK program. Results: The fraction containing the Kunitz molecule presented similar inhibition of both elastase-1 and cathepsin L. This Kunitz-type peptide was characterized as an uncompetitive inhibitor for elastase-1, presenting an inhibition constant (Ki) of 8 μM. The docking analysis led us to synthesize two peptides: PEP1, which was substrate for both elastase-1 and cathepsin L, and PEP2, a 30-mer cyclic peptide, which showed to be a cathepsin L competitive inhibitor, with a Ki of 1.96 µM, and an elastase-1 substrate. Conclusion: This work describes a Kunitz-type peptide toxin presenting inhibitory potential over serine and cysteine proteases, and this could contribute to further understand the envenomation process by D. polylepis. In addition, the PEP2 inhibits the cathepsin L activity with a low inhibition constant.(AU)
Subject(s)
Animals , Snake Venoms/analysis , Snake Venoms/chemical synthesis , Peptides/isolation & purification , Protease Inhibitors/analysis , Elapidae , Serine/biosynthesis , Serine/isolation & purification , Cysteine/biosynthesis , Cysteine/isolation & purificationABSTRACT
Rhodococcus jostii RHA1 is able to degrade toxic compounds and accumulate high amounts of triacylglycerols (TAG) upon nitrogen starvation. These NADPH-dependent processes are essential for the adaptation of rhodococci to fluctuating environmental conditions. In this study, we used an MS-based, label-free and quantitative proteomic approach to better understand the integral response of R. jostii RHA1 to the presence of methyl viologen (MV) in relation to the synthesis and accumulation of TAG. The addition of MV promoted a decrease of TAG accumulation in comparison to cells cultivated under nitrogen-limiting conditions in the absence of this pro-oxidant. Proteomic analyses revealed that the abundance of key proteins of fatty acid biosynthesis, the Kennedy pathway, glyceroneogenesis and methylmalonyl-CoA pathway, among others, decreased in the presence of MV. In contrast, some proteins involved in lipolysis and ß-oxidation of fatty acids were upregulated. Some metabolic pathways linked to the synthesis of NADPH remained activated during oxidative stress as well as under nitrogen starvation conditions. Additionally, exposure to MV resulted in the activation of complete antioxidant machinery comprising superoxide dismutases, catalases, mycothiol biosynthesis, mycothione reductase and alkyl hydroperoxide reductases, among others. Our study suggests that oxidative stress response affects TAG accumulation under nitrogen-limiting conditions through programmed molecular mechanisms when both stresses occur simultaneously.
Subject(s)
Nitrogen/deficiency , Oxidative Stress/physiology , Paraquat/metabolism , Rhodococcus/metabolism , Triglycerides/biosynthesis , Acyl Coenzyme A/metabolism , Adaptation, Physiological , Catalase/metabolism , Cysteine/biosynthesis , Fatty Acids/biosynthesis , Glycopeptides/biosynthesis , Inositol/biosynthesis , NADP/metabolism , Nitrogen/metabolism , Oxidation-Reduction/drug effects , Oxidative Stress/drug effects , Oxidoreductases/biosynthesis , Peroxiredoxins/biosynthesis , Proteome , Rhodococcus/growth & development , Superoxide Dismutase/metabolismABSTRACT
Oxidative stress occurs when cells are exposed to elevated levels of reactive oxygen species that can damage biological molecules. One bacterial response to oxidative stress involves disulfide bond formation either between protein thiols or between protein thiols and low-molecular-weight (LMW) thiols. Bacillithiol was recently identified as a major low-molecular-weight thiol in Bacillus subtilis and related Firmicutes. Four genes (bshA, bshB1, bshB2, and bshC) are involved in bacillithiol biosynthesis. The bshA and bshB1 genes are part of a seven-gene operon (ypjD), which includes the essential gene cca, encoding CCA-tRNA nucleotidyltransferase. The inclusion of cca in the operon containing bacillithiol biosynthetic genes suggests that the integrity of the 3' terminus of tRNAs may also be important in oxidative stress. The addition of the 3' terminal CCA sequence by CCA-tRNA nucleotidyltransferase to give rise to a mature tRNA and functional molecules ready for aminoacylation plays an essential role during translation and expression of the genetic code. Any defects in these processes, such as the accumulation of shorter and defective tRNAs under oxidative stress, might exert a deleterious effect on cells. This review summarizes the physiological link between tRNACys regulation and oxidative stress in Bacillus.
Subject(s)
Bacillus subtilis/genetics , RNA Nucleotidyltransferases/metabolism , RNA, Transfer, Cys/metabolism , Bacillus subtilis/metabolism , Bacterial Proteins/metabolism , Cysteine/analogs & derivatives , Cysteine/biosynthesis , Disulfides/metabolism , Glucosamine/analogs & derivatives , Glucosamine/biosynthesis , Models, Molecular , Oxidative Stress , RNA, Bacterial/metabolism , RNA, Transfer, Cys/chemistryABSTRACT
Understanding enzymatic reactions with atomic resolution has proven in recent years to be of tremendous interest for biochemical research, and thus, the use of QM/MM methods for the study of reaction mechanisms is experiencing a continuous growth. Glycosyltransferases (GTs) catalyze the formation of glycosidic bonds, and are important for many biotechnological purposes, including drug targeting. Their reaction product may result with only one of the two possible stereochemical outcomes for the reacting anomeric center, and therefore, they are classified as either inverting or retaining GTs. While the inverting GT reaction mechanism has been widely studied, the retaining GT mechanism has always been controversial and several questions remain open to this day. In this work, we take advantage of our recent GPU implementation of a pure QM(DFT-PBE)/MM approach to explore the reaction and inhibition mechanism of MshA, a key retaining GT responsible for the first step of mycothiol biosynthesis, a low weight thiol compound found in pathogens like Mycobacterium tuberculosis that is essential for its survival under oxidative stress conditions. Our results show that the reaction proceeds via a front-side SNi-like concerted reaction mechanism (DNAN in IUPAC nomenclature) and has a 17.5 kcal/mol free energy barrier, which is in remarkable agreement with experimental data. Detailed analysis shows that the key reaction step is the diphosphate leaving group dissociation, leading to an oxocarbenium-ion-like transition state. In contrast, fluorinated substrate analogues increase the reaction barrier significantly, rendering the enzyme effectively inactive. Detailed analysis of the electronic structure along the reaction suggests that this particular inhibition mechanism is associated with fluorine's high electronegative nature, which hinders phosphate release and proper stabilization of the transition state.
Subject(s)
Amidohydrolases/antagonists & inhibitors , Amidohydrolases/metabolism , Bacterial Proteins/antagonists & inhibitors , Bacterial Proteins/metabolism , Cysteine/biosynthesis , Glycopeptides/biosynthesis , Glycosyltransferases/metabolism , Inositol/biosynthesis , Metals/metabolism , Quantum Theory , Biocatalysis , Cysteine/chemistry , Glycopeptides/chemistry , Inositol/chemistry , Mycobacterium tuberculosis/metabolismABSTRACT
BACKGROUND: Cysteine, a sulfur-containing amino acid, plays an important role in a variety of cellular functions such as protein biosynthesis, methylation, and polyamine and glutathione syntheses. In trypanosomatids, glutathione is conjugated with spermidine to form the specific antioxidant thiol trypanothione (T[SH]2) that plays a central role in maintaining intracellular redox homeostasis and providing defence against oxidative stress. METHODS: We cloned and characterised genes coding for a cystathionine ß-synthase (CßS) and cysteine synthase (CS), key enzymes of the transsulfuration and assimilatory pathways, respectively, from the hemoflagellate protozoan parasite Trypanosoma rangeli. RESULTS: Our results show that T. rangeli CßS (TrCßS), similar to its homologs in T. cruzi, contains the catalytic domain essential for enzymatic activity. Unlike the enzymes in bacteria, plants, and other parasites, T. rangeli CS lacks two of the four lysine residues (Lys26 and Lys184) required for activity. Enzymatic studies using T. rangeli extracts confirmed the absence of CS activity but confirmed the expression of an active CßS. Moreover, CßS biochemical assays revealed that the T. rangeli CßS enzyme also has serine sulfhydrylase activity. CONCLUSION: These findings demonstrate that the RTS pathway is active in T. rangeli, suggesting that this may be the only pathway for cysteine biosynthesis in this parasite. In this sense, the RTS pathway appears to have an important functional role during the insect stage of the life cycle of this protozoan parasite.
Subject(s)
Cysteine/biosynthesis , Trypanosoma rangeli/enzymology , Amino Acid Sequence , Animals , Cloning, Molecular , Cystathionine beta-Synthase/genetics , Cystathionine beta-Synthase/metabolism , Cysteine Synthase/genetics , Cysteine Synthase/metabolism , Gene Expression Regulation, Enzymologic , Molecular Sequence Data , Oxidative Stress , Phosphatidylethanolamines , Species Specificity , Trypanosoma cruzi/enzymologyABSTRACT
Leishmania parasites seem capable of producing cysteine by de novo biosynthesis, similarly to bacteria, some pathogenic protists, and plants. In Leishmania spp., cysteine synthase (CS) and cystathionine ß-synthase (CBS) are expected to participate in this metabolic process. Moreover, the reverse transsulfuration pathway (RTP) is also predicted to be operative in this trypanosomatid because CBS also catalyzes the condensation of serine with homocysteine, and a gene encoding a putative cystathionine γ-lyase (CGL) is present in all the sequenced genomes. Our results show that indeed, Leishmania major CGL is able to rescue the wild-type phenotype of a Saccharomyces cerevisiae CGL-null mutant and is susceptible to inhibition by an irreversible CGL inhibitor, DL-propargylglycine (PAG). In Leishmania promastigotes, CGL and CS are cytosolic enzymes. The coexistence of de novo synthesis with the RTP is extremely rare in most living organisms; however, despite this potentially high redundancy in cysteine production, PAG arrests the proliferation of L. major promastigotes with an IC50 of approximately 65 µM. These findings raise new questions regarding the biological role of CGL in these pathogens and indicate the need for understanding the molecular mechanism of PAG action in vivo to identify the potential targets affected by this drug.
Subject(s)
Biosynthetic Pathways , Cystathionine gamma-Lyase/metabolism , Cysteine/biosynthesis , Leishmania major/enzymology , Sulfur/metabolism , Alkynes/metabolism , Enzyme Inhibitors/metabolism , Genetic Complementation Test , Glycine/analogs & derivatives , Glycine/metabolism , Inhibitory Concentration 50 , Leishmania major/genetics , Saccharomyces cerevisiae/geneticsABSTRACT
Trypanosoma cruzi is expected to synthetize de novo cysteine by different routes, among which the two-step pathway involving serine acetyltransferase and cysteine synthase (CS) is comprised. Also, cystathionine ß synthase (CBS) might contribute to the de novo generation of cysteine in addition to catalyze the first step of the reverse transsulfuration route producing cystathionine. However, neither the functionality of CS nor that of cystathionine γ lyase (CGL) has been assessed. Our results show that T. cruzi CS could participate notably more actively than CBS in the de novo synthesis of cysteine. Interestingly, at the protein level T. cruzi CS is more abundant in amastigotes than in epimastigotes. Unlike the mammalian homologues, T. cruzi CGL specifically cleaves cystathionine into cysteine and is unable to produce H(2)S. The expression pattern of T. cruzi CGL parallels that of CBS, which unexpectedly suggests that in addition to the de novo synthesis of cysteine, the reverse transsulfuration pathway could be operative in the mammalian and insect stages. Besides, T. cruzi CBS produces H(2)S by decomposing cysteine or via condensation of cysteine with homocysteine. The latter reaction leads to cystathionine production, and is catalyzed remarkably more efficiently than the breakdown of cysteine. In T. cruzi like in other organisms, H(2)S could exert regulatory effects on varied metabolic processes. Notably, T. cruzi seems to count on stage-specific routes involved in cysteine production, the multiple cysteine-processing alternatives could presumably reflect this parasite's high needs of reducing power for detoxification of reactive oxygen species.
Subject(s)
Cystathionine beta-Synthase/metabolism , Cystathionine gamma-Lyase/metabolism , Cysteine Synthase/metabolism , Cysteine/biosynthesis , Hydrogen Sulfide/metabolism , Life Cycle Stages , Trypanosoma cruzi/enzymology , Animals , Cystathionine beta-Synthase/genetics , Cystathionine gamma-Lyase/genetics , Cysteine/metabolism , Cysteine Synthase/genetics , Gene Expression Regulation, Developmental , Gene Expression Regulation, Enzymologic , Humans , Kinetics , Protozoan Proteins/genetics , Protozoan Proteins/metabolism , Sulfur/metabolism , Trypanosoma cruzi/genetics , Trypanosoma cruzi/growth & developmentABSTRACT
It has been well-documented that leukotrienes (LTs) are released in allergic lung inflammation and that they participate in the physiopathology of asthma. A role for LTs in innate immunity has recently emerged: Cys-LTs were shown to enhance FcgammaR-mediated phagocytosis by alveolar macrophages (AMs). Thus, using a rat model of asthma, we evaluated FcgammaR-mediated phagocytosis and killing of Klebsiella pneumoniae by AMs. The effect of treatment with a cys-LT antagonist (montelukast) on macrophage function was also investigated. Male Wistar rats were immunized twice with OVA/alumen intraperitoneally and challenged with OVA aerosol. After 24 h, the animals were killed, and the AMs were obtained by bronchoalveolar lavage. Macrophages were cultured with IgG-opsonized red blood cells (50:1) or IgG-opsonized K. pneumoniae (30:1), and phagocytosis or killing was evaluated. Leukotriene C(4) and nitric oxide were quantified by the EIA and Griess methods, respectively. The results showed that AMs from sensitized and challenged rats presented a markedly increased phagocytic capacity via FcgammaR (10X compared to controls) and enhanced killing of K. pneumoniae (4X higher than controls). The increased phagocytosis was inhibited 15X and killing 3X by treatment of the rats with montelukast, as compared to the non-treated group. cys-LT addition increased phagocytosis in control AMs but had no effect on macrophages from allergic lungs. Montelukast reduced nitric oxide (39%) and LTC(4) (73%). These results suggest that LTs produced during allergic lung inflammation potentiate the capacity of AMs to phagocytose and kill K. pneumonia via FcgammaR.
Subject(s)
Asthma/immunology , Cysteine/physiology , Leukotrienes/physiology , Lung/immunology , Macrophages, Alveolar/immunology , Acetates/pharmacology , Allergens/pharmacology , Animals , Cyclopropanes , Cysteine/biosynthesis , Cysteine/chemistry , Disease Models, Animal , Klebsiella pneumoniae/immunology , Leukotriene Antagonists/pharmacology , Leukotriene C4/metabolism , Leukotrienes/biosynthesis , Leukotrienes/chemistry , Lung/metabolism , Lung/pathology , Macrophages, Alveolar/drug effects , Male , Nitric Oxide/metabolism , Ovalbumin/pharmacology , Phagocytosis , Pneumonia/immunology , Pneumonia/metabolism , Pneumonia/pathology , Quinolines/pharmacology , Rats , Rats, Wistar , Receptors, IgG/metabolism , Receptors, IgG/physiology , SulfidesABSTRACT
BACKGROUND: Mycelium-to-yeast transition in the human host is essential for pathogenicity by the fungus Paracoccidioides brasiliensis and both cell types are therefore critical to the establishment of paracoccidioidomycosis (PCM), a systemic mycosis endemic to Latin America. The infected population is of about 10 million individuals, 2% of whom will eventually develop the disease. Previously, transcriptome analysis of mycelium and yeast cells resulted in the assembly of 6,022 sequence groups. Gene expression analysis, using both in silico EST subtraction and cDNA microarray, revealed genes that were differential to yeast or mycelium, and we discussed those involved in sugar metabolism. To advance our understanding of molecular mechanisms of dimorphic transition, we performed an extended analysis of gene expression profiles using the methods mentioned above. RESULTS: In this work, continuous data mining revealed 66 new differentially expressed sequences that were MIPS(Munich Information Center for Protein Sequences)-categorised according to the cellular process in which they are presumably involved. Two well represented classes were chosen for further analysis: (i) control of cell organisation - cell wall, membrane and cytoskeleton, whose representatives were hex (encoding for a hexagonal peroxisome protein), bgl (encoding for a 1,3-beta-glucosidase) in mycelium cells; and ags (an alpha-1,3-glucan synthase), cda (a chitin deacetylase) and vrp (a verprolin) in yeast cells; (ii) ion metabolism and transport - two genes putatively implicated in ion transport were confirmed to be highly expressed in mycelium cells - isc and ktp, respectively an iron-sulphur cluster-like protein and a cation transporter; and a putative P-type cation pump (pct) in yeast. Also, several enzymes from the cysteine de novo biosynthesis pathway were shown to be up regulated in the yeast form, including ATP sulphurylase, APS kinase and also PAPS reductase. CONCLUSION: Taken together, these data show that several genes involved in cell organisation and ion metabolism/transport are expressed differentially along dimorphic transition. Hyper expression in yeast of the enzymes of sulphur metabolism reinforced that this metabolic pathway could be important for this process. Understanding these changes by functional analysis of such genes may lead to a better understanding of the infective process, thus providing new targets and strategies to control PCM.
Subject(s)
Gene Expression Regulation, Fungal/genetics , Mycelium/genetics , Paracoccidioides/genetics , Yeasts/genetics , Biological Transport/genetics , Blotting, Northern/methods , Cation Transport Proteins/genetics , Cell Wall/genetics , Cell Wall/metabolism , Cysteine/biosynthesis , Cytoskeleton/genetics , Cytoskeleton/metabolism , Expressed Sequence Tags , Fungal Proteins/genetics , Gene Expression Profiling/methods , Ions/metabolism , Oligonucleotide Array Sequence Analysis/methods , Yeasts/cytology , beta-Glucosidase/geneticsABSTRACT
The synthesis of L-cysteine, the major mechanism by which sulfur is incorporated into organic compounds in microorganisms, occupies a significant fraction of bacterial metabolism. In Bacillus subtilis the cysH operon, encoding several proteins involved in cysteine biosynthesis, is induced by sulfur starvation and tightly repressed by cysteine. We show that a null mutation in the cysK gene encoding an O-acetylserine-(thiol)lyase, the enzyme that catalyzes the final step in cysteine biosynthesis, results in constitutive expression of the cysH operon. Using DNA microarrays we found that, in addition to cysH, almost all of the genes required for sulfate assimilation are constitutively expressed in cysK mutants. These results indicate that CysK, besides its enzymatic role in cysteine biosynthesis, is a global negative regulator of genes involved in sulfur metabolism.
Subject(s)
Bacillus subtilis/enzymology , Cysteine Synthase/metabolism , Gene Expression Regulation, Bacterial , Sulfur/metabolism , Bacillus subtilis/genetics , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Carbon-Oxygen Lyases/genetics , Carbon-Oxygen Lyases/metabolism , Cysteine/biosynthesis , Cysteine Synthase/genetics , Escherichia coli , Gene Fusion , Genes, Reporter , Oligonucleotide Array Sequence Analysis , Operon , beta-Galactosidase/analysis , beta-Galactosidase/geneticsABSTRACT
A 0.5 kb fragment of Streptomyces venezuelae ISP5230 genomic DNA was amplified by PCR using primers based on consensus sequences of cysteine synthase isozyme A from bacteria. The deduced amino acid sequence of the PCR product resembled not only cysteine synthase sequences from prokaryotes and eukaryotes but also eukaryotic cystathionine beta-synthase sequences. Probing an Str. venezuelae genomic library with the PCR product located a hybridizing colony from which pJV207 was isolated. Sequencing and analysis of the Str. venezuelae DNA insert in pJV207 detected two ORFs. The deduced amino acid sequence of ORF1 matched both cysteine synthase and cystathionine beta-synthase sequences in GenBank, but its size favoured assignment as a cystathionine beta-synthase. ORF2 in the pJV207 insert was unrelated in function to ORF1; in its sequence the deduced product resembled acetyl-CoA transferases, but disruption of the ORF did not cause a detectable phenotypic change. Disruption of ORF1 failed to elicit cysteine auxotrophy in wild-type Str. venezuelae, but in the cys-28 auxotroph VS263 it prevented restoration of prototrophy with homocysteine or methionine supplements. The change in phenotype implicated loss of the transsulfuration activity that in the wild-type converts these supplements to cysteine. This study concludes that disruption of ORF1 inactivates a cbs gene, the product of which participates in cysteine synthesis by transsulfuration. Enzyme assays of Str. venezuelae mycelial extracts confirmed the formation of cysteine by thiolation of O-acetylserine, providing the first unambiguous detection of this activity in a streptomycete. Enzyme assays also detected cystathionine gamma-synthase, cystathionine beta-lyase and cystathionine gamma-lyase activity in the extracts and showed that the substrate for cystathionine gamma-synthase was O-succinyl-homoserine. Based on assay results, the cys-28 mutation in Str. venezuelae VS263 does not inactivate the cysteine synthase gene but impairs expression in cultures grown in minimal medium.
Subject(s)
Cystathionine beta-Synthase/genetics , Cystathionine beta-Synthase/metabolism , Cysteine/biosynthesis , Streptomyces/enzymology , Sulfur/metabolism , Amino Acid Sequence , Cloning, Molecular , Culture Media , Cysteine Synthase/genetics , Cysteine Synthase/metabolism , Gene Deletion , Genetic Complementation Test , Methionine/biosynthesis , Molecular Sequence Data , Sequence Analysis, DNA , Serine/biosynthesis , Streptomyces/genetics , Streptomyces/growth & developmentABSTRACT
The molecular mechanisms of regulation of the genes involved in the biosynthesis of cysteine are poorly characterized in Bacillus subtilis and other gram-positive bacteria. In this study we describe the expression pattern of the B. subtilis cysH operon in response to sulfur starvation. A 6.1-kb polycistronic transcript which includes the cysH, cysP, ylnB, ylnC, ylnD, ylnE, and ylnF genes was identified. Its synthesis was induced by sulfur limitation and strongly repressed by cysteine. The cysH operon contains a 5' leader portion homologous to that of the S box family of genes involved in sulfur metabolism, which are regulated by a transcription termination control system. Here we show that induction of B. subtilis cysH operon expression is dependent on the promoter and independent of the leader region terminator, indicating that the operon is regulated at the level of transcription initiation rather than controlled at the level of premature termination of transcription. Deletion of a 46-bp region adjacent to the -35 region of the cysH promoter led to high-level expression of the operon, even in the presence of cysteine. We also found that O-acetyl-L-serine (OAS), a direct precursor of cysteine, renders cysH transcription independent of sulfur starvation and insensitive to cysteine repression. We propose that transcription of the cysH operon is negatively regulated by a transcriptional repressor whose activity is controlled by the intracellular levels of OAS. Cysteine is predicted to repress transcription by inhibiting the synthesis of OAS, which would act as an inducer of cysH expression. These novel results provide the first direct evidence that cysteine biosynthesis is controlled at a transcriptional level by both negative and positive effectors in a gram-positive organism.
Subject(s)
Bacillus subtilis/genetics , Cysteine/biosynthesis , Gene Expression Regulation, Bacterial , Genes, Bacterial , Operon , Sulfur/metabolism , Transcription, Genetic , Bacillus subtilis/metabolism , Base Sequence , Cysteine/genetics , DNA Primers , Molecular Sequence Data , Nucleic Acid Conformation , Polymerase Chain Reaction , Promoter Regions, Genetic , RNA, Bacterial/chemistry , RNA, Bacterial/genetics , Sulfotransferases/metabolism , Sulfur/pharmacology , Terminator Regions, GeneticABSTRACT
Growth on readily utilizable sulfur sources reduces expression of the cysteine regulon in Salmonella typhimurium. Inhibition of serine transacetylase by cysteine and direct actions of the anti-inducers sulfide and thiosulfate are responsible for reduction of expression. In order to evaluate individual contributions of each mechanism, the inhibitory effects of Na2S and Na2S2O3 were studied in strains with or without the capacity to synthesize cysteine from these compounds, using a transcriptional fusion to the cysDNC operon. In a cysK cysM strain, although cysteine synthesis from sulfide and thiosulfate was blocked, Na2S and Na2S2O3 efficiently reduced expression of the cysDNC operon. The inhibitory effect observed in this mutant was equivalent to 70-100% of that found in a strain carrying the fusion in a wild-type context grown in the same conditions. The actions of sulfide and thiosulfate as anti-inducers seem therefore to be responsible for most of the reduction of expression caused by these agents in vivo.
Subject(s)
Cysteine/biosynthesis , Regulon/genetics , Salmonella typhimurium/genetics , Sulfides/pharmacology , Thiosulfates/pharmacology , Bacterial Proteins/genetics , Gene Expression Regulation, Bacterial , Genotype , Mutation , Operon , Salmonella typhimurium/metabolism , Serine/analogs & derivatives , Serine/metabolism , Sulfides/metabolism , Thiosulfates/metabolism , Transcription, GeneticABSTRACT
Random Tn917 mutagenesis of Bacillus subtilis followed by selection of lipoic acid auxotrophs led to the isolation of the cysH gene. The gene was sequenced and found to encode a phosphoadenylylsulfate sulfotransferase with a molecular mass of 27 kDa. Expression of lacZ fused to the cysH promoter was repressed by cysteine and sulfide and induced by sulfur limitation, indicating that cysH is controlled at the level of transcription.